e-learning
resources
Munich 2014
Monday, 08.09.2014
Resistance, bacteriological profile and comorbidities in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of prophylactic clarithromycin administration on quality of life in non-CF bronchiectasis patients
E. Fouka, S. Anevlavis, K. Kaltsas, A. Antoniadis, D. Bouros (Thessaloniki, Alexandroupolis, Serres, Greece)
Source:
International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Session:
Resistance, bacteriological profile and comorbidities in respiratory infections
Session type:
Thematic Poster Session
Number:
2541
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Fouka, S. Anevlavis, K. Kaltsas, A. Antoniadis, D. Bouros (Thessaloniki, Alexandroupolis, Serres, Greece). Effects of prophylactic clarithromycin administration on quality of life in non-CF bronchiectasis patients. Eur Respir J 2014; 44: Suppl. 58, 2541
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
The use of home intravenous antibiotics in adult non-CF bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Influence of inhaled glucocorticosteroids on course of the bronchiectasis
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by
pseudomonas aeruginosa
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
A meta-analysis of health related quality of life (HRQOL) in non-cystic fibrosis bronchiectasis (NCFB): Association with clinical outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Validation of a visual analogue score (LRTI-VAS) in non-CF bronchiectasis
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Assessment of quality of life in patients with bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Systematic review of the validity of health related quality of life (HRQOL) questionnaires in non-cystic fibrosis bronchiectasis (NCFB)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Intranasal budesonide improves quality of life in patient with COPD and chronic nasal symptoms
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Effect of long term azithromycin on exacerbations in non CF bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings
Year: 2013
Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2009; 34: 125-131
Year: 2009
The association between objective CT measures of bronchiectasis and health-related quality of life in COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home?
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Quality of life in obstructive lung diseases
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Effect of roflumilast on quality of life in frequent and infrequent exacerbators
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
A randomised comparison of two tobramycin formulations in cystic fibrosis (CF) patients with chronic
pseudomonas aeruginosa
(PA) infection for pharmacokinetic and therapeutic equivalence
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
The frequency of exacerbations in COPD patients and its influence on the effects of pulmonary rehabilitation
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept